High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling.
Fibroblast growth factor 2 (FGF-2) is a multifunctional protein synthesized as high (Hi-) and low (Lo-) molecular weight isoforms. Studies using rodent models showed that Hi- and Lo-FGF-2 exert distinct biological activities: after myocardial infarction, rat Lo-FGF-2, but not Hi-FGF-2, promoted sust...
Main Authors: | Jon-Jon Santiago, Leslie J McNaughton, Navid Koleini, Xin Ma, Brian Bestvater, Barbara E Nickel, Robert R Fandrich, Jeffrey T Wigle, Darren H Freed, Rakesh C Arora, Elissavet Kardami |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4020823?pdf=render |
Similar Items
-
Together and apart: inhibition of DNA synthesis by connexin-43 and its relationship to transforming growth factor-beta
by: Maya Madhumathy Jeyaraman, et al.
Published: (2013-07-01) -
The role of cardiac fibroblasts in remodelling and reverse remodelling of the myocardium of the heart
by: Clark, Lucy A.
Published: (2009) -
Expression and release of high molecular weight fibroblast growth factor-2 by cardiac myofibroblasts
by: Santiago, Jon-Jon Rodrin
Published: (2013) -
Expression and release of high molecular weight fibroblast growth factor-2 by cardiac myofibroblasts
by: Santiago, Jon-Jon Rodrin
Published: (2013) -
Studies on high molecular weight fibroblast growth factor-2 isoforms produced by rat and human cardiac myofibroblasts
by: Santiago, Jon-Jon
Published: (2014)